Related Experiment Video

Updated: Nov 25, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.6K

TRPV6 Is Associated with Prognosis of ST-Elevation Acute Myocardial Infarction

Huiying Zhang1, Pengfei Ding2, Lei Zheng3

  • 1School of Statistics, ShanXi University of Finance and Economics, Taiyuan, Shanxi Province.

Annals of Clinical and Laboratory Science
|December 18, 2020
PubMed

Insights

Lower expression of Transient Receptor Potential Vanilloid 6 (TRPV6) is linked to poorer outcomes in ST-elevation acute myocardial infarction (STEMI) patients. This suggests TRPV6 may be a biomarker for STEMI prognosis.

Area of Science:

  • Cardiology
  • Biomarkers
  • Molecular Biology

Background:

  • ST-elevation acute myocardial infarction (STEMI) is a critical cardiovascular event.
  • Understanding novel biomarkers for STEMI prognosis is crucial for patient management.

Purpose of the Study:

  • To investigate the association between Transient Receptor Potential Vanilloid 6 (TRPV6) expression and clinical outcomes in STEMI patients.
  • To explore the relationship between TRPV6 levels and various clinical and laboratory parameters in STEMI.

Main Methods:

  • Observational study including 221 STEMI patients, 50 NSTEMI patients, and 50 healthy controls.
  • Serum TRPV6 levels measured by ELISA; correlation analysis with clinical characteristics, cardiac biomarkers (CK-MB, TnI, NT-pro-BNP, CRP), and LVEF.
  • Kaplan-Meier curves used for survival analysis.

Main Results:

  • Serum TRPV6 levels were significantly lower in STEMI and NSTEMI patients compared to healthy controls.
  • Deceased STEMI patients exhibited lower TRPV6 and higher NT-pro-BNP and CK-MB levels.
  • Lower TRPV6 levels correlated with reduced LVEF, higher GRACE scores, elevated cardiac biomarkers, and increased incidence of adverse cardiovascular events and mortality.

Conclusions:

  • Reduced TRPV6 expression is associated with adverse clinical outcomes and poor prognosis in STEMI patients.
  • TRPV6 may serve as a potential biomarker for predicting prognosis in STEMI.
Abstract

Keywords:
ST-elevation acute myocardial infarctionTRPV6prognosis

More Related Videos

Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy07:05

Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy

Published on: September 27, 2024

685
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.7K

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
96
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
157
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
205
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
335
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.4K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
179